Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
5.62
0.18 (3.31%)
At close: Jun 27, 2025, 12:34 PM
3.31% (1D)
| Bid | 5.6 |
| Market Cap | 316.88M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -108.04M |
| EPS (ttm) | -1.88 |
| PE Ratio (ttm) | -2.99 |
| Forward PE | -2.43 |
| Analyst | Buy |
| Ask | 5.63 |
| Volume | 59,304 |
| Avg. Volume (20D) | 487,422 |
| Open | 5.44 |
| Previous Close | 5.44 |
| Day's Range | 5.41 - 5.64 |
| 52-Week Range | 3.56 - 12.92 |
| Beta | 0.38 |
About ATXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+7.48%
Astria Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago · businesswire.com
Astria Therapeutics to Present at Upcoming Eastern Allergy ConferenceBOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that ...
